Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Stuart Peterson’s Artis Capital Raised Stake in $AMRS

Stuart Peterson’s Artis Capital raised its passive stake in Amyris, Inc. (AMRS) to 12.91%, according to the firm’s SEC 13G filing on November 10th. The file shows Artis Capital takes 5,807,768 shares in AMRS, which is a 118% expansion based on 2,659,299 shares it held in Q2. The file also indicates that Artis Capital might start to make the purchase on October 5th. AMRS dropped by nearly 40% in early November due to its third quarter loss. Now the stock is trading at $12.53, representing a 53% decrease year to date.

Three hedge funds were bullish about AMRE in the second quarter. Beside Artis Capital’s 2.66 million shares position, David E. Shaw’s D E Shaw & Co had 92 thousand shares, and Bruce Kovner’s Caxton Associates had29 thousand shares in the stock.

CAXTON ASSOCIATES LP

Artis Capital is a San Francisco-based hedge fund. The firm was established in 2001 and invests mainly in public technology companies. Besides, the firm has small positions in Healthcare, Financial, Consumer Goods, Basic Material, and some other sector. The firm invested $8 million venture capital in YouTube and then successfully sold it for $1.65 billion to Google.

Amyris, Inc. is an integrated renewable products company. The company mainly offers renewable compounds, as well as builds and applies its industrial synthetic biology platform to provide alternatives to select petroleum-sourced products for a variety of markets. The company was known as Amyris Biotechnologies, Inc. before June 2010. The company was founded in 2003 and is based in Emeryville, California.

Loading...